140 related articles for article (PubMed ID: 20846714)
1. Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study.
Randall LM; Monk BJ; Moon J; Parker R; Al-Ghazi M; Wilczynski S; Fruehauf JP; Markman M; Burger RA
Gynecol Oncol; 2010 Dec; 119(3):417-21. PubMed ID: 20846714
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study.
Tewari D; Monk BJ; Al-Ghazi MS; Parker R; Heck JD; Burger RA; Fruehauf JP
Gynecol Oncol; 2005 Oct; 99(1):84-91. PubMed ID: 16109440
[TBL] [Abstract][Full Text] [Related]
3. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
4. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Varia MA; Bundy BN; Deppe G; Mannel R; Averette HE; Rose PG; Connelly P
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1015-23. PubMed ID: 9869224
[TBL] [Abstract][Full Text] [Related]
5. Development of an in vitro chemo-radiation response assay for cervical carcinoma.
Monk BJ; Burger RA; Parker R; Radany EH; Redpath L; Fruehauf JP
Gynecol Oncol; 2002 Nov; 87(2):193-9. PubMed ID: 12477451
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Whitney CW; Sause W; Bundy BN; Malfetano JH; Hannigan EV; Fowler WC; Clarke-Pearson DL; Liao SY
J Clin Oncol; 1999 May; 17(5):1339-48. PubMed ID: 10334517
[TBL] [Abstract][Full Text] [Related]
7. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
Nugent EK; Case AS; Hoff JT; Zighelboim I; DeWitt LL; Trinkhaus K; Mutch DG; Thaker PH; Massad LS; Rader JS
Gynecol Oncol; 2010 Mar; 116(3):438-41. PubMed ID: 19896180
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.
Stehman FB; Ali S; Keys HM; Muderspach LI; Chafe WE; Gallup DG; Walker JL; Gersell D
Am J Obstet Gynecol; 2007 Nov; 197(5):503.e1-6. PubMed ID: 17980189
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
12. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
13. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2011 Jun; 121(3):542-5. PubMed ID: 21420157
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
[TBL] [Abstract][Full Text] [Related]
17. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
18. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study.
Walker JL; Morrison A; DiSilvestro P; von Gruenigen VE;
Gynecol Oncol; 2009 Jan; 112(1):78-84. PubMed ID: 19010522
[TBL] [Abstract][Full Text] [Related]
20. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
